Mar 17 / 2021

UTI ‘test and treat’ kit launched by Superdrug and TestCard

Superdrug and TestCard have partnered up to launch non-invasive UTI ‘test and treat’ kit

Superdrug and TestCard have teamed up to launch a non-invasive UTI kit that allows patients to ‘test and treat’ their condition without having to physically go to a clinic.

The non-invasive kits, created by TestCard, leverages technology that turns the patients’ smartphone camera into a clinical grade scanner. Studies have proven that this technology is just as effective as the professional dipstick reading services employed by doctors.

Test results are displayed on the app along with “negative”, “possible UTI”, or “high possibility of a UTI” readings. In addition, patients are able to transfer their test results to their GP, the Superdrug Online Doctor service or an alterative healthcare professional.

Michael Henry, Superdrug’s healthcare directorMichael Henry, Superdrug’s healthcare director, said in a press release:

When the NHS is as stretched as it is, we’re delighted to be able to support our customers and offer this new at home UTI test and treat service which is easy, accessible and convenient and will also help to reduce the pressure on GP services.

Superdrug Health ambassador Dr Zoe Williams shared:

Superdrug now provides this option to check if their urinary symptoms are likely to be a UTI. However, always speak to your doctor straight away if you have symptoms of a more serious infection, such as a high temperature, severe pain or blood in the urine.

Andrew Botham, co-founder & chief scientific officer at TestCardAndrew Botham, co-founder & chief scientific officer at TestCard, added:

TestCard’s aim is to make testing fast, accurate, and accessible for all. There’s no medical jargon or complicated numbers, and Superdug online doctors can then use the more detailed analysis to decide how best to treat you. TestCard is able to provide alternative routes to important treatment for those that need it.

Source: Med-Tech Innovation News

Share this entry: gplus-button facebook-button linkedin-button twitter-button
or go back to NEWS page